USPTO serial 79282659
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $975
Qingdao KingAgroot CropScience Co., Ltd.
CN
Other trademarks owned by Qingdao KingAgroot CropScience Co., Ltd.
Qingdao KingAgroot Resistant Weed Management Co., Ltd.
Huangdao District, Qingdao City Shandong, CN
Other trademarks owned by Qingdao KingAgroot Resistant Weed Management Co., Ltd.
Qingdao KingAgroot Resistant Weed Management Co., Ltd.
Huangdao District, Qingdao City Shandong, CN
Other trademarks owned by Qingdao KingAgroot Resistant Weed Management Co., Ltd.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Zhi Dong
Zhi Dong Hamre, Schumann, Mueller & Larson, P.C.45 South Seventh Street, Suite 2700Minneapolis, MN 55402UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Tensio-active agents in the nature of surface active compounds for general use in the industrial arts, namely, as wetting, spreading, emulsifying, dispersing and penetrating agents; industrial chemicals; agricultural chemicals, except fungicides, herbicides, insecticides and parasiticides; preparations of trace elements for plants for nutrition; chemical preparations for scientific purposes, other than for medical or veterinary use; fertilizers; plant growth regulating preparations; soil conditioning preparations; nutrient preparations for plants; hormones for hastening the ripening of fruit | ACTIVE | — |
| 005 | Medicines for human purposes, namely, medicinal preparations for the inhibition of gene expression, transcription, or translation processes at DNA or RNA, for modulation of immune system, for treatment and prevention of Alzheimer's disease, depression, respiratory, cardiovascular, metabolic, oncological, infectious, hormonal, endocrinological, lymphatic, virological, immunological, cardiopulmonary and liver disease, cancer and viral infections; pharmaceutical preparations, namely, biological agents and preparations for the inhibition of gene expression, transcription, or translation processes at DNA or RNA, for modulation of immune system, for treatment and prevention of Alzheimer's disease, depression, respiratory, cardiovascular, metabolic, oncological, infectious, hormonal, endocrinological, lymphatic, virological, immunological, cardiopulmonary and liver disease, cancer and viral infections; cultures of microorganisms for medical or veterinary use; dietetic beverages adapted for medical use; dietetic foods adapted for medical purpose; depuratives for the body; medicines for veterinary purposes for treating tumor and cancer; pesticides; herbicides; fungicides for agricultural purposes; medical dressings | ACTIVE | — |
| 031 | Living trees; unprocessed grain; live plants; live animals; fruit, fresh; vegetables, fresh; plant seeds; seeds for agricultural purposes; crop seeds; fodder | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 24, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 10, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 11, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 27, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 27, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 24, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 24, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 28, 2020 | UNDC | UNDELIVERABLE MAIL - COURTESY COPY MAILED | — |
| Sep 28, 2020 | XAAP | EXAMINER'S AMENDMENT AFTER PUB APPROVAL | — |
| Sep 8, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 8, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 19, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 5, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 5, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 5, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 5, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 5, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 28, 2020 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 28, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jul 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 15, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 25, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 25, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 17, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 16, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 9, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |